Pay in 4 interest-free payments of $5.58 Learn more
:max_bytes(150000):strip_icc()/HEALTH-DWL-frame-final-zepbound-660e231e08ed4501aac307f06936227c.jpg)
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
Retatrutide (also known as LY3437943) is a next-generation investigational peptide developed by Eli Lilly for the treatment of obesity and Type 2 diabetes
Just as a patient with hypertension takes blood pressure medication daily to prevent a stroke, a patient with obesity takes semaglutide to prevent the recurrence of weight gain and its associated complications
Peptide drugs affect the body's functions and are often used for bodybuilding, anti-aging, or enhancing athletic performance
She's also embraced exercise for the first time in her life
US$ 21.84
US$ 22.60
US$ 26.52
US$ 26.74
